Skip to main content
Article thumbnail
Location of Repository

The mutagenicity of the reaction of DNA with genotoxic carcinogens

By Keith I.E. McLuckie

Abstract

Mechanisms by which carcinogens induce mutations in human cells can be investigated using carcinogen exposed shuttle vector plasmids. In particular, the pSP189 plasmid can be treated with carcinogens in vitro and transfected into human fibroblasts. Following replication, where DNA repair or mutagenesis occurs, recovered plasmids can be screened in indicator bacteria for induced mutations in the supF gene.\ud The aim of this study was to establish and utilise assays to investigate the mutagenicity of genotoxic agents. Specifically, two model reactive intermediates of the cancer drug tamoxifen, α-acetoxytamoxifen and 4-hydroxytamoxifen quinone methide (4-OHtamQM), along with binary treatments of BPDE with UVB or UVC radiation were assessed for their mutagenic potential in human cells.\ud The quantitatively minor DNA adduct of tamoxifen formed by 4-OHtamQM is more mutagenic than the major tamoxifen adduct, formed by a-acetoxytamoxifen in Ad293 cells. The majority of mutations in α-acetoxytamoxifen treated plasmid were GC→TA transversions, while GC→AT transitions were predominant in 4-OHtamQM treated plasmid. Mutational hotspots were observed for both compounds. In GM04429 cells mutations induced by α-acetoxytamoxifen were mainly GC→TA, whereas in GM00637 fibroblasts GC→AT transitions were more common.\ud Treatment of plasmid with BPDE preferentially induced GC→TA transversions whilst UVB and UVC induced GC→AT transitions. Binary treatments were more mutagenic than single treatments, with BPDE then UV being more mutagenic than UV then BPDE. This suggests a synergistic mechanism of activation of BPDE DNA adducts by UV radiation.\ud In the final part of this work, a system for investigating the site-selectivity and consequences of mutagen reaction with DNA was developed. In the future this methodology can be used to detect mutations arising from specific DNA adducts inserted at known locations in important genes. This assay builds on the results provided by the standard supF assay and enables a more detailed investigation of the mechanisms involved in mutagenesis

Publisher: University of Leicester
Year: 2003
OAI identifier: oai:lra.le.ac.uk:2381/7934

Suggested articles

Citations

  1. (1986). 06-methylguanine mutation and repair is nonuniform. Selection for DNA most interactive with 06-methylguanine.
  2. 12,2001; revised March 19,2001; accepted
  3. (1982). 32P-postlabcling analysis of nonradioactive aromatic carcinogen-DNA adducts.
  4. (1981). 32P-postlabelling test for DNA damage.
  5. (1970). 5-Thyminyl-5,6-dihydrothymine from DNA irradiated with ultraviolet light.
  6. (1982). 5,6-Saturated thymine lesions in DNA: production by ultraviolet light or hydrogen peroxide.
  7. (1994). A Comparative-Study of Tamoxifcn Metabolism in Female Rat, Mouse and Human Liver-Microsomcs.
  8. (1994). A Mechanistic Hypothesis for DNA Adduct Formation by Tamoxifen Following Hepatic Oxidative-Metabolism. Carcinogenesis,
  9. (1983). A new patient with both Xeroderma pigmentosum and Cockayne syndrome establishes the new Xeroderma pigmentosum complementation group H.
  10. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA.
  11. (1985). A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells.
  12. (1992). A signature element distinguishes sibling and independent mutations in a shuttle vector plasmid.
  13. (1995). A simple p53 functional assay for scrccning cell lines, blood and tumours.
  14. (1979). A sixth complementation group in excision-deficient Xeroderma pigmentosum.
  15. (2000). Accommodation of S-cisTamoxifen-N2-Guanine Adduct within a Bent and Widened Minor Groove.
  16. (1990). Acetylaminofluorene bound to different guanines of the sequence -GGCGCC- is excised with different efficiencies by the UvrABC excision nuclease in a pattern not correlated to the potency of mutation induction.
  17. (1981). Action spectra for ultraviolet light-induced transformation of human cells to anchorageindependent growth.
  18. (1996). Activation of tamoxifen and its metabolite alphahydroxytamoxifen to DNA-binding products: Comparisons between human, rat and mouse hepatocytes.
  19. (1989). Adjuvant Tamoxifen in Early Breast-Canccr - Occurrence of New Primary Cancers.
  20. (1995). Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies.
  21. (1994). aHydroxytamoxifen ,a Metabolite of Tamoxifen with Exceptionally High DNA- binding Activity in Rat Hepatocytes.
  22. (1998). aHydroxytamoxifen Is a Substrate of Hydroxysteroid (Alcohol) Sulfotransferase, Resulting in Tamoxifen DNA Adducts. Cancer Res.,
  23. (1988). Alternative pathways for the in vivo repair of 06-alkylguanine and 04-alkylthymine in Escherichia coil: the adaptive response and nucleotide excision repair.
  24. (1974). An N-glycosidasc from Eschcrichla coil that releases free uracil from DNA containing dcaminatcd cytosine residues.
  25. (1994). Analysis of 4"nitroquinolinc-l-oxidc induced mutations at the hprt locus in mammalian cells: possible involvement of preferential DNA repair.
  26. (1997). Analysis of the Malondialdehyde-2'-Deoxyguanosine Adduct Pyrimidopurinone in Human Leukocyte
  27. and collaborators (1991) p53 mutation in hepatocellular carcinoma after aflatoxin exposure. The Lancet,
  28. (1996). Base analog and neighboring base effects on substrate specificity of recombinant human G: T mismatch-specific thymine DNA-glycosylase.
  29. (1999). Base excision repair of N-mcthylpurincs in a yeast minichromosome.
  30. (1964). Bcnzo(a)pyrcnc and other polynuclcar hydrocarbons in charcoal-broiled meat.
  31. (1976). Benzo[a]pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo.
  32. (1976). Benzo[ajpyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo.
  33. (1895). Bladder tumours in Fuchsine workers.
  34. (2000). Cancer Res.
  35. (1902). Cancroid des rechten Handrucken nach lang daurden Einwirkung von Roentgenstrahlen.
  36. (1984). Carcinogen-Induced Mutation Spectrum in Wild"Typc, Uvra and Umiuc Strains of Escherichia-Coll - Strain Specificity and Mutation"Pronc Scquences.
  37. (1998). Carcinogenesis
  38. (1994). Carcinogenesis 15.439-442. 8906
  39. (1983). Characterization of Polycyclic Aromatic-Hydrocarbons as Essential Carcinogenic Constituents of Coal Combustion and Automobils Exhaust Using Mouse-Skin-Painting as a Carcinogen- Specific Detector.
  40. (1775). Chirurgical observations relative to the cataract, the polypus of the nose, the cancer of the scrotum, the different kinds of ruptures and the mortification of the toes and feet.
  41. (1989). Comparing the frequency and spectra of mutations induced when an SV 40 based shuttle vector containing covalently bound residues of structurally- related carcinogens replicates in human cells.
  42. (1989). Comparing the frequency and spectra of mutations induced when an SV-40 based shuttle vector containing covalently bound residues of structurally-related carcinogens replicates in human cells.
  43. (1994). Comparison of the sites of reaction of 3 polycyclic aromatic- hydrocarbons in the supF gene.
  44. (1997). Comparisons of the binding of [14C]radiolabelled tamoxifen or toremifene to rat DNA using accelerator mass spectrometry.
  45. (1999). Context-dependent mutagcnesis by DNA lesions.
  46. (1979). Conversion of cnvironmcntal pollutant to mutagcns by visible light.
  47. (1979). Conversion of environmental pollutant to mutagens by visible light.
  48. (1998). Correlation between sequence-dependent glycosylase repair and the thermal stability of oligonuclcotide duplexes containing 1,
  49. (1991). Covalent bonding of bay-region diol cpoxides to nucleic acids.
  50. (1997). CYP2D6 catalyzes tamoxifcn 4-hydroxylation in human liver.
  51. (1981). Damage to DNA caused by hydrolysis.
  52. (1991). Dependence of the mutation spectrum in a shuttle vector plasmid replicated in human lymphoblasts on dose of gamma radiation.
  53. (2001). Detection of DNA and protein adducts in (''CJ-tamoxifen treated women by accelerator mass spectrometry (AMS). / lutat.
  54. (1997). Detection of DNA damage by Escherichia coli UvrB-binding competition assay is limited by the stability of the UvrB-DNA complex.
  55. (1997). Detection of DNA modifications by the 32P-postlabelling assay.
  56. (1998). Determination of malondialdchyde-induced DNA damage in human tissues using an immunoslot blot assay. Carcinogenesis,
  57. (1988). Determination of the spectrum of mutations induced by defined-wavelength solar WD (313-nm) radiation in mammalian cells by use of a shuttle vector.
  58. (1983). Determining Exposure and Biochemical Effects in HumanPopulation Studies. Environ. Health Perspect.,
  59. (1983). Dicthylstilbcstrol (DES) quinone: a reactive intermediate
  60. (1998). Differential cleavage of oligonuclcotidcs containing the bcnzcnc-dcrivcd adduct 1, N6. bcnzcthcno-dA, by the major human
  61. (2002). Distinct spectrum of mutations induced by crocidolite asbestos: Clue for 8-hydroxydeoxyguanosine-dependent mutagenesis in vivo.
  62. (1981). Distribution of UV light-induced damage in a defined sequence of human DNA: detection of alkaline-sensitive lesions at pyrimidinc nucleoside-cytidinc sequences.
  63. (2002). DNA adducts formed from
  64. (1994). DNA Adducts: Identification and biological significance.
  65. (1979). DNA glycosylascs, cndonuclcascs for apurinic / apyrimidinic sites and base excision repair.
  66. (1990). DNA photolyases: physical properties, action mechanism, and roles in dark repair.
  67. (1993). DNA Repair Helicase: A Component of BTF2 (TFIIH) Basic Transcription Factor.
  68. (1994). DNA repair rates mapped along Chapter 7 Appendices and References
  69. (1986). DNA to protein crosslinks and backbone breaks caused by far- and near-ultraviolet and visible radiations in mammalian cells.
  70. (1987). DNA, light, and Dewar pyrimidones: the structure and biological significance of TpT3.
  71. (1984). DNA"Rcpair Protects against Cutaneous and Internal Ncoplasia - Evidence from Xcrodcrma Pigmcntosum. Carcinogenesis,
  72. (1992). DNApolymerase, RNA-polymerase and exonuclease activities on a DNA-sequence modified by benzo[a]pyrene diol epoxide.
  73. (1989). Effect of 3' flanking neighbors on kinetics of pairing of dCTP or dTTP opposite 06-methylguanine in a defined primed oligonucleotide when Escherichia coli DNA polymerase I is used.
  74. (2001). Effect of Sequence Context on 06. Methylguanine Repair and Replication In Vivo.
  75. (1993). Effect of sequence, adduct type and opposing lesions on the binding and repair of ultraviolet photodamage by DNA photolyase and (A)BC excinuclease.
  76. (1949). Effect of visible light on recovery of Streptomyces grlscus conidia from ultraviolet irradiation injury.
  77. (1997). Effects of chronic administration of tamoxifen and torcmifcnc on DNA adducts in rat liver, kidney, and uterus.
  78. (1985). Enhanced sensitivity of 32P-postlabelling analysis of aromatic carcinogen-DNA adducts.
  79. (1999). Enhancement of DNA damage and involvement of reactive oxygen species after exposure of bitumen with UVA irradiation.
  80. (1999). Enhancement of DNA damage and involvement of reactive oxygen species after exposure to bitumen with UVA irradiation.
  81. (1993). Environmental risk factors for skin cancer. Recent Res. Cancer Res.,
  82. (1999). Enzymology of the Repair of Etheno Adducts
  83. (1980). Epidemiology of asbestosrelated diseases.
  84. (1988). Estrogens as a Cause of Human Cancer - the Richard-and-Hinda- Rosenthal-Foundation Award Lecture. Cancer Res.,
  85. (1998). Evaluation of tamoxifcn and a-hydroxytamoxifen "P-postlabelled DNA adducts by the development of a novel automated on-line solid-phase extraction HPLC method.
  86. (2000). Excision of Tamoxifen-DNA Adducts by the Human Nucleotide Excision Repair System. Cancer Res.,
  87. (1918). Experimental study of the pathogenesis of carcinoma.
  88. (2000). Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens.
  89. (1975). Five complementation groups in Xeroderma pigmentosum. Mut a:.
  90. (2000). Formation of DNA adducts and induction of mutagenic effects in rats following 4 weeks inhalation exposure to ethylene oxide as a basis for cancer risk assessment.
  91. (1972). Genetic heterogeneity of Xeroderm pigmentosum demonstrated by somatic cell hybidisation.
  92. (1998). Genotyping of mass spcctromctric analysis of short DNA fragments.
  93. (1974). heat-induced dcamination of cytosine residues in DNA.
  94. (1973). heat-induced depyrimidination of deoxyribonucleic acid in neutral solution.
  95. (1998). Heterogeneous repair of Nmethylpurines at the nucleotide level in normal human cells.
  96. (1985). Hydroxy derivatives of tamoxifcn.
  97. (1985). Hypersensitivity of Xeroderma Pigmentosum-Cells to Dietary Carcinogens.
  98. (1997). Identification of tamoxifcn"DNA adducts formed by 4-hydroxytamoxifen quinone methide.
  99. (1995). Identification of Tamoxifen Metabolites
  100. (2000). Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen.
  101. (1996). Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen.
  102. (1999). Identification of the major tamoxifen-DNA adducts in rat liver by mass spectroscopy.
  103. (1988). IIPLC Enrichment of Hydrophobic DNA -Carcinogen Adducts for Enhanced Sensitivity of 32P. Postlabcling Analysis.
  104. (1992). In vitro
  105. (1999). Induced mutations in Ml3mp2 phage DNA exposed to Nnitrosopynrolidine with UVA irradiation.
  106. (1983). Induction of DNA strand breaks in normal human fibroblasts exposed to monochromatic ultraviolet and visible wavelengths in the 240-546 nm range.
  107. (1966). Induction of hepatic cell carcinomas in monkeys with N"nitrosodicthylamine.
  108. (1983). Infidelity of DNA-synthesis associated with bypass of apurinic sites.
  109. (1985). Influence of neighboring bases on DNA polymerase insertion and proofreading fidelity.
  110. (1987). Inhibition of 06-alkylguanine-DNAalkyltransferase by metals.
  111. (1983). Insertion of nucleotides opposite apurinic apyrimidinic sites in deoxyribonucleic-acid during In Vitro synthesis - Uniqueness of adenine-nucleotides Biochemistry,
  112. (1997). Investigation of the formation and accumulation of liver DNA adducts in mice chronically expose to tamoxifcn.
  113. (1995). Is Dermatological Usage of Coal-Tar Carcinogenic -a Review of the Literature.
  114. (1995). Is dermatological usage of coal-tar carcinogenic-a review of the literature.
  115. (1987). Kinds of mutations formed when a shuttle vector containing adducts of (f)-7ß, 8a-dihydroxy-9a, 10a, -epoxy-7,8,9,10-tetrahydobenzo[a]pyrene replicates in human cells.
  116. (1970). Kinetics and mechanism of the acid-catalyzed hydrolysis of some purine nucleosides.
  117. (1995). Laser pulse-induced photochemical strand cleavage of sitespecifically and covalently modified (+)-anti-benzo[a]pyrene diol epoxideoligonucleotide adducts.
  118. (1998). Lifetime and reactivity of an ultimate tamoxifen carcinogen: The tamoxifen carbocation.
  119. (1980). Malignant Melanoma: Social Status and Outdoor
  120. Martini-L Cancer Biomarkers and Prevention Group, The Biocentre,
  121. (2002). Mass Spectrometry in Cancer Research.
  122. (1983). Mechanisms of chemical mutagenesis and carcinogenesis: effects on DNA replication of methylation at the 06-guanine position of dGTP.
  123. (1990). Melphalan-induced Mutagenesis in an SV40-based Shuttle Vector: Predominance of A. T-T. A Transversions. Cancer Res.,
  124. (1993). Metabolism of the Antimammary Cancer Anticstrogcnic Agent Tamoxifcn . 2. Flavin-Containing Monooxygcnasc- Mediated N- Oxidation. Drug Uctabolism and Disposition,
  125. (1995). Microsomal and peroxidase activation of 4-hydroxytamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen.
  126. (1997). Minor products of reaction with DNA of a-acetoxytamoxifen.
  127. (1997). Miscoding potential of tamoxifen-derived DNA adducts: a-(N2-deoxyguanosinyl) tamoxifen.
  128. (1990). Modern methods of DNA adduct determination.
  129. (1998). Molecular analysis of mutations induced by acrolcin in human fibroblast cclls using supF shuttle vector plasmids.
  130. (1968). Molecular beams of macroions.
  131. (1983). Molecular Biology of Mutagens and Carcinogens.
  132. (1976). Molecular Biology of the Gene.
  133. (1987). Multiple point mutations in a shuttle vector propagated in human cells: Evidence for an error-prone DNA polymerase activity.
  134. (1987). Multiple point mutations in a shuttle vector propagated in human cells: evidence for an errorprone DNA polymerase activity.
  135. (1998). Mutagcnic replication in a human ccll extract of DNAs containing site-specific and stcrcospccific bcnzo(a)pyrcnc-7,8-diolChapter 7 Appendices and References 9,10-epoxide DNA adducts placed on the leading and lagging strands.
  136. (1998). Mutagcnic Specificity of a Derivative of 3-Nitrobcnzanthrone in the supF Shuttle Vector Plasmids.
  137. (1986). Mutagenesis by Apurinic Apyrimidinic Sites.
  138. (1993). Mutagenesis by the (+)-anti-diol epoxide of benzo[a]pyrene: what controls mutagenic specificity?
  139. (1993). Mutagenesis by the (+)-antidiol epoxide of benzo[alpyrene: what controls mutagenic specificity?
  140. (1985). Mutagenic specificity of ultraviolet light.
  141. (1999). Mutation and DNA modification in Salmonella exposed to Nnitrosodimethylamine under UVA- and sunlight-irradiation.
  142. (1997). Mutation and formation of methyl- and hydroxylguanine adducts
  143. (2000). Mutation spectra in supF: approaches to elucidating sequence context effects.
  144. (2000). Mutational spectra for polycyclic aromatic hydrocarbons in the supF target gene.
  145. (1993). Mutational spectra of the (+)-anti-diol epoxide of benzo[a]pyrene in a supF gene of an Escherichia coli plasmid: DNA sequence context influences hotspots, mutational specificity and the extent of SOS enhancement of mutagenesis.
  146. (1993). Mutational spectra of the (+)-antidiol epoxide of benzo[alpyrene in a supF gene of an Escherichia coil plasmid: DNA sequence context influences hotspots, mutational specificity and the extent of SOS enhancement of mutagenesis.
  147. (1989). Mutations induced by aminofluorcnc-DNA adducts during replication in human cells. Carcinogen es is,
  148. (2000). Mutations induced by reactive nitrogen oxide species in the supF forward mutation assay.
  149. (1997). Mutations Induced in a Shuttle Vector Plasmid Exposed to Monofunctionally Activated Mitomycin C.
  150. (1999). N-Demethylation accompanies a-hydroxylation in the metabolic activation of tamoxifen in rat liver cells.
  151. (1994). Nitrite-induced mutations in a forward mutation assay: Influence of nitrite concentration and pH.
  152. (1930). Occupational cancers.
  153. (2000). Optical properties of rainbow trout lenses after in vitro exposure to polycyclic aromatic hydrocarbons in the presence or absence of ultraviolet radiation.
  154. (2002). Oxidation of 7,8-Dihydro-8-oxoguanine Affords Lesions that arc Potent Sources of Replication Errors in Vivo.
  155. (1991). p53 Mutations in human cancers.
  156. (1994). p53 status and efficacy of cancer therapy
  157. (1994). P53-A glimpse at the puppet behind the shadow play.
  158. (1992). PCNA-induced DNA synthesis past cis-syn and trans-syn-I thymine dimers by calf thymus DNA polymerase 8 in vitro.
  159. (1995). Pcroxidasc Activation of Tamoxifcn and Torcmifcnc Resulting
  160. (1982). Photoactivated afatoxins are mutagenic to Salmonella typhimurium and bind to DNA in vitro.
  161. (1982). Photoactivated aflatoxins arc mutagens to Salmonella tjphimurium and bind covalently to DNA In vitro.
  162. (1972). Photochemistry of nucleic acids and their constituents.
  163. (1998). Photoinduced electron transfer and strand cleavage in pyrenyl-DNA complexes and adducts.
  164. (1987). Photoproduct frequency is not the major determinant of UV base substitution hot spots or cold spots in human cells.
  165. (2000). Phototoxic evaluation of marine sediments collected from a PAH-contaminated site.
  166. (1990). Polycyclic aromatic hydrocarbons: metabolism, activation and tumour initiation. In
  167. (2002). Prepararion of Oligodeoxynucleotides Containing a Diastercoisomcr of cz-(N2-2'-Deoxyguanosinyl)tamoxifen by Phosphoramidite Chemical Synthesis.
  168. (1990). Presence of benzo[a]pyrene diol epoxide adducts in target DNA leads to an increase in UV induced DNA single strand breaks and supF gene mutations
  169. (2001). Presence of benzo[a]pyrene diol epoxide adducts in target DNA leads to an increase in UV-induced DNA single strand breaks and supF gene mutations.
  170. (1996). Production of 8-hydroxy-2'-deoxyguanosine in DNA by microsomal activation of tamoxifen and 4-hydroxytamoxifen.
  171. (1977). Properties of the liver microsomal monoxygcnasc system and epoxide hydrasc: factors influencing the metabolism and mutagcnicity of bcnzo(a)pyrcnc.
  172. (1990). Radical Reactions In vivo - an Overview.
  173. (1999). Rapid Commun. Mass Spectrom.
  174. (1972). Rate of dcpurination of native deoxyribonucleic acid.
  175. (1949). Reactivation of ultraviolet inactivated bactcriophage by visible light.
  176. (1995). Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers.
  177. (1996). Relationships between DNA repair and Transcription.
  178. (1991). Relevance to human cancer of Nnitroso compounds, tobacco smoke and mycotoxins,
  179. (1996). Repair and processing of DNA damage: a summary of recent progress.
  180. (1989). Repair of 06-methylguanine by ABC excinuclease of Escherichia coli in vitro.
  181. (1987). Repair of a mismatch is influenced by
  182. (1991). Replication of acctylaminofluorcnc-adductcd plasmids in human cells: Spectrum of base substitutions and evidence of excision rcpair.
  183. (2000). Respective roles of cyclobutane pyrimidine dimers, (6-4') photoproducts, and minor phototproducts in ultraviolet mutagenesis of repairdeficient Xeroderma pigmentosum A cells.
  184. (2000). Respective roles of cyclobutane pyrmidine dimers, (6-4)photoproducts, and minor photoproducts in ultraviolet mutagenesis of repair-deficient xeroderma pigmentosum A cells.
  185. (1984). Scrotal cancer in the West Midlands 1936-1976.
  186. (1990). Sequence specificity in the reaction of benzopyrene diol epoxide with DNA.
  187. (1992). Sequence Specificity of Aflatoxin 131-induced Mutations in a Plasmid Replicated in Xeroderma Pigmentosum and DNA Repair Proficient Human Cells.
  188. (1992). Sequence specificity of aflatoxin Bt-induced mutations in a plasmid replicated in xeroderma-pigmentosum and DNA-repair proficient human cells.
  189. (1988). Sequence specificity of guanine alkylation and repair.
  190. (1999). Sequence-dependent repair of synthetic AP sites in 15-mer and 35-mer oligonucleotides: role of thermodynamic stability imposed by neighbor bases.
  191. (1994). Shuttle-vector mutagenesis by aflatoxin B-1 in human cells-effects of sequence context on the supF mutational spectrum.
  192. (1968). Sibs with mental and physical retardation and trichorrhexis nodosa with abnormal amino acid composition of the hair.
  193. (1996). Single nucleotidc positions have proximal and distal influence on UV mutation hotspots and coldspots.
  194. (1996). Single nucleotide positions have proximal and distal influence on UV mutation hotspots and Goldspots,
  195. (1999). Site-specific mutagenesis with benzo[a]pyrene-deoxribonucleoside adducts. Polycyclic Aromatic Compounds,
  196. (1991). Site-specific mutagenesis: retrospective and prospective.
  197. (1995). Site-specific rates of excision repair of benzo[a]pyrene diol epoxide adducts in the hypoxanthine phosphoribosyltransferase gene of human fibroblasts: correlation with mutation spectra.
  198. (1999). Site-specific tamoxifen-DNA adduct formation: lack of correlation with mutational ability in Escherichia coll.
  199. (1999). Sitespecific tamoxifen-DNA adduct formation: lack of correlation with mutational ablility in Escherichia coll.
  200. (1994). Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer.
  201. (1992). Solar and Ultraviolet Radiation.
  202. (1988). Solution-state structure of the Dewar pyrimidinone photoproduct of thymidylyl-(3'-5')-thymidine.
  203. (1984). Some Chemical and Biochemical Aspects of Liver Microsomal Metabolism of Tamoxifen. Drug Metab.
  204. (1982). Species variance in the metabolic activation of polycyclic hydrocarbons.
  205. (1991). Spectra of spontaneous and mutagen"induccd mutations in the lacl gene in transgenic mice.
  206. (1991). Spectra of spontaneous and mutageninduced mutations in the lacl gene in transgenic mice.
  207. (1992). Spontaneous and ultraviolet-induced mutations on a singlc-strandcd shuttle vector transfected into monkey cells A.
  208. (2001). Spontaneous mutation spectra in supF: comparative analysis of mammalian cell line base substitution spectra. Mutagenesis,
  209. (1991). Spontaneous Mutation.
  210. (1996). Stable transformation of xeroderma pigmentosum group A cells with an XPA minigene restores normal DNA repair and mutagenesis of UV-treated plasmids.
  211. (1990). Studies of the Mortality of A-Bomb Survivors; Mortality,
  212. (1993). Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction.
  213. (1996). Tamoxifcn: some pharmaceutical drugs.
  214. (1996). Tamoxifcn" induced DNA adducts in endometrial samples from breast canccr patients.
  215. (1997). Tamoxifcn"induccd DNA adducts in leucocytes of breast cancer patients.
  216. (1997). Tamoxifen causes gene mutations in the livers of lambda/lacl transgenic rats.
  217. (1996). Tamoxifen does not form detectable DNA adducts in white blood cells of breast cancer patients.
  218. (1999). Tamoxifen-DNA adducts detected in the endometrium of women treated with tamoxifen.
  219. (1994). Tamoxifen: evidence Chapter 7 Appendices and References
  220. (1984). Testing of New Drugs.
  221. (1968). The alkaline degradation of deoxyribonucleic acid derivatives.
  222. (2000). The Ames Salmonella/microsome mutagenicity assay.
  223. (2002). The APC gene in colorectal cancer.
  224. (1999). The Biological Basis of Cancer.
  225. (1995). The Dcutcrium-Isotopc Effect for the a"llydroxylation of Tamoxifcn by Rat-Livcr Microsomcs Accounts for the Rcduccd Gcnotoxicity of
  226. (2000). The Dewar photoproduct or thymidylyl(3'-5')-thymidine (Dewar product) exhibits mutagcnic behaviour in accordance with the "A rule".
  227. (1996). The influence of single base changes on UV mutational activity at two translocation hotspots.
  228. (1966). The molecular basis of biological effects of ultraviolet radiation and photoreactivation.
  229. (1931). The occurrence of malignancy in radioactive persons.
  230. (1968). The photochemistry, photobiology, and repair of polynucleotides.
  231. (1956). The production of malignant primary hepatic tumours in the rat by feeding dimethylnitrosaminc.
  232. (1986). The role of the (64') photoproduct in ultraviolet light-induced transition mutations in E.
  233. (1991). The thymine-thyminc pyrimidine-pyrimidone (6-4') ultraviolet-light photoproduct is highly mutagcnic and specifically induces 3' thyminc-to-cytosinc transitions in Escherichla coll.
  234. (1978). The use of logistic regression for modelling risk factors: with application to non-melanoma skin cancer.
  235. (1993). Two-ycar carcinogenixcity study of tamoxifen in Aldcrlcy Park Wistar-dcrivcd rats.
  236. (2000). UK and USA breast cancer deaths down 25% in year
  237. (1981). Ultraviolct light action spcctra for ncoplastic transformation and Icthality of Syrian hamster cmbryo cclls corrclate with spcctrum for pyrimidinc dimcr formation in cellular DNA.
  238. (1961). Ultraviolet light induced linking of deoxyribonucleic acid strands and its reversal by photorcactivating enzyme.
  239. (1976). Ultraviolet mutagenesis and inducible DNA repair in Escherichia coll.
  240. (1989). Use of supF, an Eschcrlchia coil tyrosine suppressor tRNA gene, as a mutagcnic target in shuttic-vector plasmids.
  241. (1997). Uterine carcinoma in mice treated neonatally with Tamoxifen. Carcinogenesis,
  242. (1982). UV induced mutation hotspots occur at DNA damage hot spots.
  243. (1986). UV light-induced cyclobutane pyrimidine dimers are mutagenic in mammalian cells.
  244. (1991). UVA (320-380 nm) radiation as an oxidative stress.
  245. (1999). UVB-induced acute toxicity of pyrene to the waterfiea Daphnia magna in natural freshwaters.
  246. (1999). UVB-induced acute toxicity of pyrene to the waterflea Daphnia magna in natural freshwaters.
  247. (1993). Variation of single-strand break yield with scavenger concentration for plasmid DNA irradiated in aqueous solution.
  248. (1963). Variations in skin cancer incidence within the United States.
  249. (1999). Wavelength dependence of ultraviolet-induced DNA damage distribution: involvement of direct or indirect mechanisms and possible artefacts.
  250. (1987). Xerodcrma plgmentosum : cutaneous, ocular and neurological abnormalities in 830 published cases.
  251. (1975). Xeroderma pigmentosum cells with normal levels of excision repair have a defect in DNA synthesis after UV-irradiation.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.